Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $234.09 million. The enterprise value is $106.93 million.
| Market Cap | 234.09M |
| Enterprise Value | 106.93M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALDX has 59.41 million shares outstanding. The number of shares has increased by 0.92% in one year.
| Shares Outstanding | 59.41M |
| Shares Change (YoY) | +0.92% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 1.99% |
| Owned by Institutions (%) | 61.49% |
| Float | 42.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.64, with a Debt / Equity ratio of 0.13.
| Current Ratio | 6.64 |
| Quick Ratio | n/a |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.12 |
Financial Efficiency
Return on equity (ROE) is -29.40% and return on invested capital (ROIC) is -31.59%.
| Return on Equity (ROE) | -29.40% |
| Return on Assets (ROA) | -24.20% |
| Return on Capital (ROIC) | -31.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.75M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.61% in the last 52 weeks. The beta is 1.53, so ALDX's price volatility has been higher than the market average.
| Beta (1Y) | 1.53 |
| 52-Week Price Change | -56.61% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 4.47 |
| Relative Strength Index (RSI) | 53.13 |
| Average Volume (30 Days) | 589,485 |
Short Selling Information
The latest short interest is 2.36 million, so 3.97% of the outstanding shares have been sold short.
| Short Interest | 2.36M |
| Short Previous Month | 2.05M |
| Short % of Shares Out | 3.97% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 3.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -42.79M |
| Pretax Income | -37.54M |
| Net Income | -37.54M |
| EBITDA | -35.21M |
| EBIT | -35.47M |
| Earnings Per Share (EPS) | -$0.64 |
Balance Sheet
The company has $142.82 million in cash and $15.66 million in debt, giving a net cash position of $127.17 million or $2.14 per share.
| Cash & Cash Equivalents | 142.82M |
| Total Debt | 15.66M |
| Net Cash | 127.17M |
| Net Cash Per Share | $2.14 |
| Equity / Book Value | 119.80M |
| Book Value Per Share | 2.02 |
| Working Capital | 125.55M |
Cash Flow
| Operating Cash Flow | -30.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.33M |
| FCF Per Share | -$0.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.92% |
| Shareholder Yield | -0.92% |
| Earnings Yield | -16.04% |
| FCF Yield | -12.95% |
Analyst Forecast
The average price target for ALDX is $9.33, which is 136.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.33 |
| Price Target Difference | 136.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |